For over 30 years, the Immune Deficiency Foundation (IDF) has offered a full spectrum of educational publications, programs and resources developed by experts for patients, families and healthcare professionals. Many of IDF’s resources have been translated into other languages, and many of IDF’s publications have been used as the basis for translations from other National Organizations as well.
We’ve created this International Section to make it easier to sort through the available resources. As more resources become available, we will be expanding this section.
The International Patient Organization for Primary Immunodeficiencies (IPOPI) is an international organization whose members are national patient organizations for primary immunodeficiencies. The site provides general information on primary immunodeficiency and resource contacts for patients and professionals worldwide.
IPOPI also has many publications and resources in different languages, so be sure to visit www.ipopi.org.
A network of patients, doctors, researchers and other experts, created for the care and advocacy of primary immunodeficiencies in Africa.
Pediatricians and scientists from Asia interested in the care and treatment of primary immunodeficiencies.
The European Society for Immunodeficiencies (ESID) is a non-profit medical organization. The purpose of ESID is to foster excellence in research and medical practice and to promote interaction with nurses and patient associations, so as to increase exchange of information among patients, parents of patients, nurses, doctors and researchers.
The purpose of the International Nursing Group for Immunodeficiencies (INGID) is to improve and extend the quality of nursing care of patients with primary immunodeficiencies, and to increase the awareness and understanding of primary immunodeficiencies amongst
The Latin American Society for Primary Immunodeficiencies (LASID) is a professional organization comprised of physicians from various Latino countries who are dedicated to promoting the awareness, diagnosis and treatment of primary immunodeficiency diseases in these countries.